Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
